These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 26973216

  • 1. A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens.
    Lung J, Lin YC, Hung MS, Jiang YY, Lee KD, Lin PY, Tsai YH.
    Lung Cancer; 2016 Apr; 94():114-20. PubMed ID: 26973216
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues.
    Zhang YG, Jin ML, Li L, Zhao HY, Zeng X, Jiang L, Wei P, Diao XL, Li X, Cao Q, Tian XX.
    PLoS One; 2013 Apr; 8(5):e64821. PubMed ID: 23741400
    [Abstract] [Full Text] [Related]

  • 3. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
    Gruber K, Horn H, Kalla J, Fritz P, Rosenwald A, Kohlhäufl M, Friedel G, Schwab M, Ott G, Kalla C.
    J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
    [Abstract] [Full Text] [Related]

  • 4. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

  • 5. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
    Rosenblum F, Hutchinson LM, Garver J, Woda B, Cosar E, Kurian EM.
    Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
    [Abstract] [Full Text] [Related]

  • 6. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ.
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [Abstract] [Full Text] [Related]

  • 7. Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer.
    Dama E, Tillhon M, Bertalot G, de Santis F, Troglio F, Pessina S, Passaro A, Pece S, de Marinis F, Dell'Orto P, Viale G, Spaggiari L, Di Fiore PP, Bianchi F, Barberis M, Vecchi M.
    Oncotarget; 2016 Jun 14; 7(24):37160-37176. PubMed ID: 27206799
    [Abstract] [Full Text] [Related]

  • 8. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH, Choe G, Kim H, Choe JY, Lee HJ, Lee CT, Lee JS, Jheon S, Chung JH.
    J Thorac Oncol; 2011 Mar 14; 6(3):466-72. PubMed ID: 21258247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.
    Wang W, Tang Y, Li J, Jiang L, Jiang Y, Su X.
    Cancer Cytopathol; 2015 Feb 14; 123(2):117-22. PubMed ID: 25529354
    [Abstract] [Full Text] [Related]

  • 12. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
    Vollbrecht C, Lenze D, Hummel M, Lehmann A, Moebs M, Frost N, Jurmeister P, Schweizer L, Kellner U, Dietel M, von Laffert M.
    BMC Cancer; 2018 Nov 22; 18(1):1158. PubMed ID: 30466405
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).
    Kotoula V, Bobos M, Vassilakopoulou M, Tsolaki E, Chrisafi S, Psyrri A, Lazaridis G, Papadopoulou K, Efstratiou I, Michail-Strantzia C, Debelenko LV, Kosmidis P, Fountzilas G.
    Appl Immunohistochem Mol Morphol; 2015 Jan 22; 23(1):60-70. PubMed ID: 25153496
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
    Alì G, Proietti A, Pelliccioni S, Niccoli C, Lupi C, Sensi E, Giannini R, Borrelli N, Menghi M, Chella A, Ribechini A, Cappuzzo F, Melfi F, Lucchi M, Mussi A, Fontanini G.
    Arch Pathol Lab Med; 2014 Nov 22; 138(11):1449-58. PubMed ID: 24885803
    [Abstract] [Full Text] [Related]

  • 18. [A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens].
    Wang Z, Wu X, Shi Y, Han X, Cheng G, Li L, Mu X, Zhang Y, Cui D, Zhang L, Fan Z, Zhu G, Ma L, Yang L, Di J, Liu D.
    Zhonghua Zhong Liu Za Zhi; 2015 Oct 22; 37(10):742-8. PubMed ID: 26813592
    [Abstract] [Full Text] [Related]

  • 19. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
    Mescam-Mancini L, Lantuéjoul S, Moro-Sibilot D, Rouquette I, Souquet PJ, Audigier-Valette C, Sabourin JC, Decroisette C, Sakhri L, Brambilla E, McLeer-Florin A.
    Lung Cancer; 2014 Feb 22; 83(2):168-73. PubMed ID: 24380695
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.